# Empagliflozin

## Jardiance 25mg

##### 

| 藥品代碼   | OJAR2                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|:-----------|:------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 適應症     | Diabetes mellitus， type 2                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| 用法用量   | Initial 10 mg once daily， may increase to 25 mg once daily as tolerated.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| 肝功能異常 | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| 腎功能異常 | 需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| 禁忌       | History of serious hypersensitivity to empagliflozin or any component of the formulation; severe renal impairment (eGFR <30 mL/minute/1.73 m2)， end-stage renal disease (ESRD)， or dialysis                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 副作用     | >10%: Endocrine & metabolic: Hypoglycemia (combination therapy with insulin: 28%， severe hypoglycemia: <=1%; combination therapy with metformin and a sulfonylurea: 12% to 16%; combination therapy with metformin: 1% to 2%) Genitourinary: Urinary tract infection (9%; females: 18%; males: 4%)， increased urine output (includes polyuria， pollakiuria， nocturia: 3%) 1% to 10%: Endocrine & metabolic: Increased LDL cholesterol (5% to 7%)， dyslipidemia (4%)， increased thirst (including polydipsia: 2%) Gastrointestinal: Nausea (2%) Hematologic & oncologic: Increased hematocrit (3% to 4%) Infection: Genitourinary fungal infection (4%; females: 5% to 6% [includes bacterial vaginosis， cervicitis， vulvitis， vulvovaginal candidiasis， vulvovaginal infection， vulvovaginitis]; males: 2% to 3% [includes balanitis， balanoposthitis， genitourinary fungal infection， penile infection， scrotal abscess]) |
| 孕期建議   | No (limited) human data – animal data suggest low risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| 哺乳期建議 | No (Limited) Human Data – Potential Toxicity(Mother) 無(很少)資料 – 避免使用(母體)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |

